Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma20 Dec 2023 2:30 PM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Fake medical factory producing duplicate Betnovate-N busted, mastermind held Roshni Dhar19 Dec 2023 5:28 PM ISTA fake medical factory preparing duplicate ‘Betnovate-N’ was busted by the Delhi Police's Crime Branch and 2,200 filled tubes and 68,000 empty tubes...
Health Bulletin 19/December/2023 Roshni Dhar19 Dec 2023 4:15 PM ISTHere are the top health stories for the day:MCC NEET SS Counselling Round 2 BeginsNEET SS counselling round 2 has begun. The Medical Counselling...
Delhi: Factory producing duplicate of GSK's Betnovate-N busted, mastermind held Ruchika Sharma18 Dec 2023 5:00 PM IST"During search, 57 cartons containing empty tubes of Betnovate-N cream were recovered from the factory, wherein each carton was found containing 1,200...
Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
GSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for endometrial cancer Ruchika Sharma13 Dec 2023 3:30 PM ISTLondon: GSK plc has announced the European Commission (EC) has granted marketing authorisation for Jemperli (dostarlimab) in combination with...
GSK declares positive results from phase III trial for Blenrep in relapsed/ refractory multiple myeloma Ruchika Sharma28 Nov 2023 12:30 PM ISTLondon: GSK plc has announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial...
GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024 Ruchika Sharma23 Nov 2023 3:26 PM ISTLondon: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...
GSK gets positive EMA Committee opinion recommending Momelotinib for myelofibrosis patients with anaemia Ruchika Sharma15 Nov 2023 2:30 PM ISTLondon: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
GSK's India arm reports 12.5 percent Q2 profit at Rs 218 crore Ruchika Sharma13 Nov 2023 12:45 PM ISTBengaluru: GlaxoSmithKline Pharmaceuticals reported a 12.5% rise in quarterly profit as the Indian unit of UK's GSK plc saw strong demand for its...
GSK enters agreement to obtain exclusive license for hepatitis B therapy to expand bepirovirsen development Ruchika Sharma1 Nov 2023 11:30 AM ISTGSK will be responsible for upfront and potential milestone-based payments to both Janssen and Arrowhead totalling approximately USD 1 billion.
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
